Table 2.
IGF-2 and PHLDA2 levels between group1 and group 2 in the two investigated groups
| Variables | MCDA sIUGR patients | Z value | P value | Controls | Z value | P value | ||
|---|---|---|---|---|---|---|---|---|
|
|
|
|||||||
| Group 1 (n=10) | Group 2 (n=10) | Group 1 (n=10) | Group 2 (n=10) | |||||
| IGF2, ng/ml | 6.51±0.80 | 2.14±0.37 | -5.39 | <0.01 | 6.18±0.70 | 5.95±0.82 | 2.633 | >0.05 |
| PHLDA2, ng/ml | 0.32±0.13 | 0.56±0.31 | -5.38 | <0.01 | 0.42±0.32 | 0.51±0.11 | 0.012 | >0.05 |